Overview

Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

Status:
Completed
Trial end date:
2019-01-22
Target enrollment:
Participant gender:
Summary
Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and non-Japanese Healthy Subjects
Phase:
Phase 1
Details
Lead Sponsor:
OPKO Health, Inc.
OPKO Ireland Global Holdings Ltd.
Treatments:
Calcifediol